Article: CARBOGEN AMCIS AG ANNOUNCES INCORPORATION OF SYNPROTEC.

(Full text of a statement. Contact details below.)

CARBOGEN AMCIS AG Announces Incorporation of SynProTec

Increased Production Capabilities Expected

BUBENDORF, Switzerland, July 2, 2007 (PRIME NEWSWIRE) -- Switzerland-based CARBOGEN AMCIS AG is integrating SynProTec DCR Ltd. into its world leading drug development chemistry business. SynProTec DCR, a custom synthesis company based in Manchester, England, will retain its current staff of experts and leadership, who will begin operating under the newly formed entity CARBOGEN AMCIS Ltd. CARBOGEN AMCIS will officially begin managing the new business arm on July 1. Both companies are owned by Dishman ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!